Pyxis Oncology Raises $152M Series B Round

01 Apr, 2021

Pyxis Oncology Raises $152M Series B Round
Photo by Per Lööv on Unsplash

– Pyxis Oncology from Longwood Fund has closed a $152m Series B financing.
– The round was led by Arix Bioscience and co-led by RTW Investments, LP.
– New investors included Perceptive Advisors, RA Capital Management, Pfizer Ventures, BVF Partners, L.P., Janus Henderson Investors, Cormorant Asset Management, HBM Healthcare Investments, funds managed by Tekla Capital Management LLC, Acuta Capital Partners, Ridgeback Capital Investments, Surveyor Capital (a Citadel company), Laurion Capital Management, Logos Capital and LifeSci Venture Partners.

Biotechnology Health Care North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: